Sort
50,496 grants matching “lung cancer”
Cancer Risks among Textile Workers in China
$560,784Harvey Checkoway · University Of Washington · R01 · FY2010 · CA
Randomized trial of PEITC as a modifier of NNK metabolism in smokers
$560,770Jian-Min Yuan · University Of Minnesota · R01 · FY2011 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$560,724Dan R Littman · New York University School Of Medicine · R01 · FY2022 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$560,724Dan R Littman · New York University School Of Medicine · R01 · FY2023 · CA
Non-canonical functions of neutrophils
$560,631Andres Hidalgo · Yale University · R01 · FY2022 · AI
New mouse model of cisplatin-induced AKI and development of prevention therapy
$560,614Jianjun Zhao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
Safer lung cancer radiotherapy delivery using novel artificial intelligence methods
$560,469Harini Veeraraghavan · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Arsenic and child respiratory health in Bangladesh
$560,400Allan H Smith · University Of California Berkeley · R01 · FY2008 · HL
A deubiquitination module controls Treg adaptation to tumor microenvironment
$560,370Deyu Fang · Northwestern University At Chicago · R01 · FY2025 · CA
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure
$560,330Max Costa · New York University School Of Medicine · R01 · FY2022 · CA
Immune cell control of ovarian cancer
$560,328Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
$560,277Roland Jurecic · University Of Miami School Of Medicine · R01 · FY2017 · CA
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
$560,277Roland Jurecic · University Of Miami School Of Medicine · R01 · FY2020 · CA
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
$560,277Roland Jurecic · University Of Miami School Of Medicine · R01 · FY2016 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$560,248Bin Zhang · Northwestern University At Chicago · R01 · FY2023 · CA
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
$560,214Gary E Goodman · Fred Hutchinson Cancer Research Center · UM1 · FY2014 · CA
Reproductive and Developmental Toxicity of Dioxin
$560,190Richard E Peterson · University Of Wisconsin-Madison · R01 · FY2011 · ES
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
$560,138Matthew Adam Triplette · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
University of Texas SPORE in Lung Cancer
$560,104John D Minna · Ut Southwestern Medical Center · P50 · FY2013 · CA
Serum Levels of EGFR-Signaling-Network Activators/Inhibitor and Lung Cancer Risk
$560,055Gloria Yf Ho · Albert Einstein College Of Medicine · R01 · FY2012 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials
$560,046John M Buatti · University Of Iowa · U01 · FY2011 · CA
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles
$560,034Elias Sayour · University Of Florida · R01 · FY2022 · CA
Discovery of small molecule inhibitors for protein N-terminal acetyltransferase D
$560,032Rong Huang · Purdue University · R01 · FY2023 · CA
Elucidating the Role of Cancer-Associated FGL1 in Tumor Immunity and Developing FGL1-Guided Anti-LAG-3 Cancer Immunotherapy
$560,030Jun Wang · New York University School Of Medicine · R37 · FY2023 · CA
Hematopathology Diagnosis
$560,021Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA